Salvador Moncada | |
---|---|
Moncada (right) with John Vane in 1970s
|
|
Born |
Tegucigalpa, Honduras |
3 December 1944
Fields | Pharmacology |
Institutions | |
Alma mater | |
Known for | Prostacyclin |
Notable awards | |
Spouse | Dorys Lemus Princess Marie-Esméralda of Belgium (m. 1998) |
Children | 4 |
Website www |
Sir Salvador Moncada, FRS, FRCP, FMedSci (born 3 December 1944) is a Honduran-British pharmacologist and professor. He is currently the director of the Institute of Cancer Sciences at the University of Manchester.
HM King Albert II
HM Queen Paola
HRH Princess Léa
HRH Princess Marie-Christine, Mrs Gourges
HRH Princess Marie-Esméralda, Lady Moncada
In the past, he was the Research Director of the Wellcome Research Laboratories from 1986 to 1995 and, until recently, the Director of the UCL Wolfson Institute, which he established at University College London in 1996. His research interests include inflammation and vascular biology and he is currently working on the regulation of cell proliferation. He gained notoriety for his discoveries related to nitric oxide function and metabolism, and his exclusion from the 1996 Lasker Award and the 1998 Nobel Prize in medicine.
Moncada was born in Tegucigalpa, Honduras, to Salvador Moncada and Jenny Seidner on December 3, 1944, but moved to El Salvador in 1948. He studied medicine at the Facultad de Medicina, Universidad de El Salvador from 1962 to 1970. In 1971 he went to London to work on a PhD with John Vane in the Department of Pharmacology in the Institute of Basic Medical Sciences, Royal College of Surgeons. After a short period of research in the University of Honduras he moved to the Wellcome Research Laboratories (Beckenham, Kent), where he became Director of Research in 1986. In 1996 he moved to University College London, where he set up the Wolfson Institute for Biomedical Research in the Cruciform Building, which he directed until 2012.